MEDIHALER-ISO Drug Patent Profile
✉ Email this page to a colleague
When do Medihaler-iso patents expire, and when can generic versions of Medihaler-iso launch?
Medihaler-iso is a drug marketed by 3M and is included in one NDA.
The generic ingredient in MEDIHALER-ISO is isoproterenol sulfate. There are seventeen drug master file entries for this compound. Additional details are available on the isoproterenol sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEDIHALER-ISO?
- What are the global sales for MEDIHALER-ISO?
- What is Average Wholesale Price for MEDIHALER-ISO?
Summary for MEDIHALER-ISO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Patent Applications: | 33 |
| DailyMed Link: | MEDIHALER-ISO at DailyMed |
US Patents and Regulatory Information for MEDIHALER-ISO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | MEDIHALER-ISO | isoproterenol sulfate | AEROSOL, METERED;INHALATION | 010375-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
